influenza virus replication inhibitor Archives

ChemDiv Helps Advance Viriom’s Influenza Treatment to Successful Phase I Clinical Trials Completion

December 20, 2023December 20, 2023

ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio platforms, announces successful…

Viriom’s Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials

November 21, 2023November 21, 2023

Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally,…